Magnesium Malate for Health & Longevity - Quick Reference Sheet
evipedia.aidev
← Back

Magnesium Malate for Health & Longevity

Created on 08/23/2026 – Quick Reference based on Evidence Review created using AI4L / Grok 4 – Audit

Magnesium malate raises magnesium intake, dissolves better than magnesium oxide. The mineral is well-studied; this salt is not. Oral magnesium shows a small blood-pressure drop, some blood-sugar improvement when stores are low, and dose-related loose stools. With normal kidneys and low dietary magnesium, it is one way to close that gap—not a unique longevity drug or proven pain protocol. (Full Review)

Protocol

Practitioner pattern
200–400 mg/day elemental magnesium
Organic salt; adults over 70 start at 100–200 mg elemental
Time of day
Morning or split morning/afternoon
Less sedating than glycinate or L-Threonate
Single versus split
Split doses
Split doses raise net absorption and cut diarrhea; a single large bolus is more likely to stay in the colon
Time to effect
Lower Blood Pressure
4–12 weeks
Seen with oral magnesium generally; larger with hypertension or low magnesium status
Glucose Handling
4–12 weeks
When magnesium stores are low
Magnesium-Status Symptoms
4–12 weeks
Red-cell magnesium status marker

Benefits

Contraindications
  • Severe chronic kidney disease (eGFR below 30 mL/min/1.73 m²) or known hypermagnesemia
  • Complete heart block without a pacemaker (especially if intravenous magnesium is also in play)
  • Myasthenia gravis or ongoing neuromuscular blockade
  • Bowel obstruction or acute severe diarrhea
    •
Key Interactions
  • Tetracyclines and quinolones (doxycycline, ciprofloxacin); separate 2 hours before or 4–6 hours after
  • Oral bisphosphonates (alendronate, risedronate); empty-stomach bisphosphonate, magnesium several hours apart
  • Levothyroxine; separate by at least 4 hours
  • Gabapentin; separate doses, monitor seizure or pain control
  • Potassium-sparing diuretics (spironolactone, amiloride), especially if eGFR is reduced
  • Calcium-channel blockers and other antihypertensives (amlodipine, lisinopril); watch for lightheadedness
  • Proton-pump inhibitors (omeprazole, esomeprazole); long-term use
  • Other magnesium salts, high-dose calcium, and phosphate binders; count elemental magnesium across products
  • Stimulant laxatives and high-dose citrate magnesium
    •

Risk & Side Effects

  • High: Loose Stools, Nausea, and Abdominal Cramping
    •
  • Medium: Chelation of Oral Antibiotics and Bone Drugs
    •
  • Low: Hypermagnesemia in Reduced Kidney Function; Additive Blood-Pressure Lowering
    •
  • Speculative: Neuromuscular Blockade at Ordinary Oral Doses
    •

Monitoring

Marker Target Why
Red-cell magnesium 5.2–6.5 mg/dL Tissue magnesium status
Serum magnesium 2.0–2.4 mg/dL (0.82–0.99 mmol/L) Detects frank hypo- or hypermagnesemia
eGFR (creatinine) ≥90 mL/min/1.73 m²; caution <60; avoid supplement if <30 Safety gate for oral magnesium
Blood pressure <120/80 mm Hg Clinical endpoint of the magnesium-class effect
HbA1c <5.5% if metabolic risk is the aim Glucose-handling endpoint

Cadence: Baseline: serum magnesium, red-cell magnesium, eGFR (or creatinine), resting blood pressure, plus HbA1c if metabolic risk is the reason for use. Repeat at 8–12 weeks, then every 6–12 months if the dose is stable (red-cell magnesium, eGFR, home blood-pressure log).

Qualitative Assessment

  • Stool form (Bristol stool scale types 3–4 versus loose)
  • Daytime energy versus sedation
  • Muscle tightness or cramp frequency
  • Sleep-onset time if the salt is taken in the evening
  • Lightheadedness on standing if blood-pressure drugs are already in use
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.